Conditions:   Low Bone Mass;   Low Bone Mineral Density;   Males With Osteoporosis;   Osteopenia;   Osteoporosis
Interventions:   Drug: 60 mg denosumab;   Other: Placebo
Sponsor:   Amgen
Active, not recruiting - verified August 2011